Document Detail


Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
MedLine Citation:
PMID:  15546458     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oral anticoagulant monitoring is managed by general practitioners in Auckland. An audit of this service in 452 patients demonstrated that anticoagulant control was in line with recommended international guidelines, with 58.3% of international normalized ratio (INR) measurements in the therapeutic range. However, the frequency of testing was high, with the majority of patients (68%), including those on long-term treatment, having INR measurements at weekly intervals. We question the need for such frequent INR testing.
Authors:
L Young; P Ockelford; P Harper
Related Documents :
97098 - Coagulation changes following vasectomy: a study in primates.
11399578 - Hemostasis and thrombosis: clinical usefulness of combined use of platelet aggregation ...
10150468 - Detection of undiagnosed coagulopathies using routine rapid heparin neutralization.
22009338 - The weighted log-rank class under truncated binomial design: saddlepoint p-values and c...
24642208 - Immunogenicity of the q fever skin test.
9407478 - Breath test diagnosis of helicobacter pylori in peptic ulcer disease: a noninvasive pri...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Internal medicine journal     Volume:  34     ISSN:  1444-0903     ISO Abbreviation:  Intern Med J     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-11-19     Completed Date:  2005-03-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  101092952     Medline TA:  Intern Med J     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  639-41     Citation Subset:  IM    
Affiliation:
Department of Haematology, Auckland Hospital, Auckland, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Community Health Services / methods
Drug Monitoring / methods*
Female
Humans
International Normalized Ratio
Male
Middle Aged
Program Evaluation
Thromboembolism / blood,  drug therapy*
Warfarin / therapeutic use*
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
Next Document:  Five cases of non-typhoidal Salmonella endovascular infection.